Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15775272 | 1.00 | ACLY (0.31) | ACLYOXER1ALOX15 | |
| SCHEMBL12981472 | 0.97 | OXER1 (0.31) | OXER1 | |
| SCHEMBL12982406 | 0.89 | — | — | |
| SCHEMBL5855926 | 0.80 | OXER1 (0.38) | ACLYOXER1 | |
| SCHEMBL5852945 | 0.80 | OXER1 (0.38) | ACLYOXER1 | |
| SCHEMBL5853848 | 0.80 | OXER1 (0.38) | ACLYOXER1 | |
| SCHEMBL5855927 | 0.80 | OXER1 (0.38) | ACLYOXER1 | |
| SCHEMBL5852953 | 0.80 | OXER1 (0.38) | ACLYOXER1 | |
| SCHEMBL5853843 | 0.80 | OXER1 (0.38) | ACLYOXER1 | |
| SCHEMBL5855579 | 0.80 | OXER1 (0.38) | ACLYOXER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130296436-A1 | AMIDINE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED | 2013-11-07 | — | — | US | disclosed |
| WO-2012090969-A1 | AMIDINE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296436-A1 | AMIDINE COMPOUNDS AND USE THEREOF FOR PLANT DISEASE CONTROL | C5, ATL3, C1S | ACLY 513/4885OXER1 1321/4885ALOX15 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.